![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Akums Lifesciences Limited Mohali District In, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for Akums Lifesciences is one of the leading API manufacturers of Cephalosporins & Oncology APIs.
One of their significant offerings is Cefixime, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2009-005 - Rev 01
This Chemical Type CEP, issued on January 13, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1188 associated with this CEP further emphasizes